 | • レポートコード：MRC2-11QY12330 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は生体内毒性のグローバル市場について調査・分析したレポートです。種類別（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験）市場規模、用途別（免疫毒性、全身毒性、発がん性、遺伝毒性、発生毒性・生殖毒性（DART）、その他毒性エンドポイント）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別生体内毒性の競争状況、市場シェア ・世界の生体内毒性市場：種類別市場規模 2015年-2020年（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験） ・世界の生体内毒性市場：種類別市場規模予測 2021年-2026年（慢性毒性試験、亜慢性毒性試験、亜急性毒性試験、急性毒性試験） ・世界の生体内毒性市場：用途別市場規模 2015年-2020年（免疫毒性、全身毒性、発がん性、遺伝毒性、発生毒性・生殖毒性（DART）、その他毒性エンドポイント） ・世界の生体内毒性市場：用途別市場規模予測 2021年-2026年（免疫毒性、全身毒性、発がん性、遺伝毒性、発生毒性・生殖毒性（DART）、その他毒性エンドポイント） ・北米の生体内毒性市場分析：米国、カナダ ・ヨーロッパの生体内毒性市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの生体内毒性市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の生体内毒性市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの生体内毒性市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Thermo Fisher Scientific、Danaher、Charles River Laboratories、Labcorp、The Jackson Laboratory、Data Sciences International、Envigo、Eurofins Scientific、Perkinelmer、SRI International、Taconic Biosciences、Wuxi Apptec ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
In vivo toxicology is usually carried out in animals as a whole, so that experimental animals in a certain period of time, according to the actual contact mode of human exposure to a certain amount of foreign compounds, and then observe the animal may appear in the form or function changes. Mammals are commonly used in experiments, such as rats, mice, guinea pigs, rabbits, hamsters, dogs and monkeys. The general toxicity of foreign compounds, such as acute toxicity test, subchronic toxicity test and chronic toxicity test, is usually detected.
Market Analysis and Insights: Global In Vivo Toxicology Market
The global In Vivo Toxicology market size is projected to reach US$ 4447.8 million by 2026, from US$ 4194.4 million in 2020, at a CAGR of 5.6%% during 2021-2026.
Global In Vivo Toxicology Scope and Market Size
In Vivo Toxicology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In Vivo Toxicology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Thermo Fisher Scientific
Danaher
Charles River Laboratories
Labcorp
The Jackson Laboratory
Data Sciences International
Envigo
Eurofins Scientific
Perkinelmer
SRI International
Taconic Biosciences
Wuxi Apptec
Market segment by Type, the product can be split into
Chronic Toxicity Testing
Sub-Chronic Toxicity Testing
Sub-Acute Toxicity Testing
Acute Toxicity Testing
Market segment by Application, split into
Immunotoxicity
Systemic Toxicity
Carcinogenicity
Genotoxicity
Developmental and Reproductive Toxicity (DART)
Other Toxicity Endpoints
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by In Vivo Toxicology Revenue
1.4 Market by Type
1.4.1 Global In Vivo Toxicology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chronic Toxicity Testing
1.4.3 Sub-Chronic Toxicity Testing
1.4.4 Sub-Acute Toxicity Testing
1.4.5 Acute Toxicity Testing
1.5 Market by Application
1.5.1 Global In Vivo Toxicology Market Share by Application: 2020 VS 2026
1.5.2 Immunotoxicity
1.5.3 Systemic Toxicity
1.5.4 Carcinogenicity
1.5.5 Genotoxicity
1.5.6 Developmental and Reproductive Toxicity (DART)
1.5.7 Other Toxicity Endpoints
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global In Vivo Toxicology Market Perspective (2015-2026)
2.2 Global In Vivo Toxicology Growth Trends by Regions
2.2.1 In Vivo Toxicology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In Vivo Toxicology Historic Market Share by Regions (2015-2020)
2.2.3 In Vivo Toxicology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 In Vivo Toxicology Market Growth Strategy
2.3.6 Primary Interviews with Key In Vivo Toxicology Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top In Vivo Toxicology Players by Market Size
3.1.1 Global Top In Vivo Toxicology Players by Revenue (2015-2020)
3.1.2 Global In Vivo Toxicology Revenue Market Share by Players (2015-2020)
3.1.3 Global In Vivo Toxicology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global In Vivo Toxicology Market Concentration Ratio
3.2.1 Global In Vivo Toxicology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by In Vivo Toxicology Revenue in 2019
3.3 In Vivo Toxicology Key Players Head office and Area Served
3.4 Key Players In Vivo Toxicology Product Solution and Service
3.5 Date of Enter into In Vivo Toxicology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global In Vivo Toxicology Historic Market Size by Type (2015-2020)
4.2 Global In Vivo Toxicology Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global In Vivo Toxicology Market Size by Application (2015-2020)
5.2 Global In Vivo Toxicology Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In Vivo Toxicology Market Size (2015-2020)
6.2 In Vivo Toxicology Key Players in North America (2019-2020)
6.3 North America In Vivo Toxicology Market Size by Type (2015-2020)
6.4 North America In Vivo Toxicology Market Size by Application (2015-2020)
7 Europe
7.1 Europe In Vivo Toxicology Market Size (2015-2020)
7.2 In Vivo Toxicology Key Players in Europe (2019-2020)
7.3 Europe In Vivo Toxicology Market Size by Type (2015-2020)
7.4 Europe In Vivo Toxicology Market Size by Application (2015-2020)
8 China
8.1 China In Vivo Toxicology Market Size (2015-2020)
8.2 In Vivo Toxicology Key Players in China (2019-2020)
8.3 China In Vivo Toxicology Market Size by Type (2015-2020)
8.4 China In Vivo Toxicology Market Size by Application (2015-2020)
9 Japan
9.1 Japan In Vivo Toxicology Market Size (2015-2020)
9.2 In Vivo Toxicology Key Players in Japan (2019-2020)
9.3 Japan In Vivo Toxicology Market Size by Type (2015-2020)
9.4 Japan In Vivo Toxicology Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia In Vivo Toxicology Market Size (2015-2020)
10.2 In Vivo Toxicology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia In Vivo Toxicology Market Size by Type (2015-2020)
10.4 Southeast Asia In Vivo Toxicology Market Size by Application (2015-2020)
11 India
11.1 India In Vivo Toxicology Market Size (2015-2020)
11.2 In Vivo Toxicology Key Players in India (2019-2020)
11.3 India In Vivo Toxicology Market Size by Type (2015-2020)
11.4 India In Vivo Toxicology Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America In Vivo Toxicology Market Size (2015-2020)
12.2 In Vivo Toxicology Key Players in Central & South America (2019-2020)
12.3 Central & South America In Vivo Toxicology Market Size by Type (2015-2020)
12.4 Central & South America In Vivo Toxicology Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Details
13.1.2 Thermo Fisher Scientific Business Overview
13.1.3 Thermo Fisher Scientific In Vivo Toxicology Introduction
13.1.4 Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2015-2020))
13.1.5 Thermo Fisher Scientific Recent Development
13.2 Danaher
13.2.1 Danaher Company Details
13.2.2 Danaher Business Overview
13.2.3 Danaher In Vivo Toxicology Introduction
13.2.4 Danaher Revenue in In Vivo Toxicology Business (2015-2020)
13.2.5 Danaher Recent Development
13.3 Charles River Laboratories
13.3.1 Charles River Laboratories Company Details
13.3.2 Charles River Laboratories Business Overview
13.3.3 Charles River Laboratories In Vivo Toxicology Introduction
13.3.4 Charles River Laboratories Revenue in In Vivo Toxicology Business (2015-2020)
13.3.5 Charles River Laboratories Recent Development
13.4 Labcorp
13.4.1 Labcorp Company Details
13.4.2 Labcorp Business Overview
13.4.3 Labcorp In Vivo Toxicology Introduction
13.4.4 Labcorp Revenue in In Vivo Toxicology Business (2015-2020)
13.4.5 Labcorp Recent Development
13.5 The Jackson Laboratory
13.5.1 The Jackson Laboratory Company Details
13.5.2 The Jackson Laboratory Business Overview
13.5.3 The Jackson Laboratory In Vivo Toxicology Introduction
13.5.4 The Jackson Laboratory Revenue in In Vivo Toxicology Business (2015-2020)
13.5.5 The Jackson Laboratory Recent Development
13.6 Data Sciences International
13.6.1 Data Sciences International Company Details
13.6.2 Data Sciences International Business Overview
13.6.3 Data Sciences International In Vivo Toxicology Introduction
13.6.4 Data Sciences International Revenue in In Vivo Toxicology Business (2015-2020)
13.6.5 Data Sciences International Recent Development
13.7 Envigo
13.7.1 Envigo Company Details
13.7.2 Envigo Business Overview
13.7.3 Envigo In Vivo Toxicology Introduction
13.7.4 Envigo Revenue in In Vivo Toxicology Business (2015-2020)
13.7.5 Envigo Recent Development
13.8 Eurofins Scientific
13.8.1 Eurofins Scientific Company Details
13.8.2 Eurofins Scientific Business Overview
13.8.3 Eurofins Scientific In Vivo Toxicology Introduction
13.8.4 Eurofins Scientific Revenue in In Vivo Toxicology Business (2015-2020)
13.8.5 Eurofins Scientific Recent Development
13.9 Perkinelmer
13.9.1 Perkinelmer Company Details
13.9.2 Perkinelmer Business Overview
13.9.3 Perkinelmer In Vivo Toxicology Introduction
13.9.4 Perkinelmer Revenue in In Vivo Toxicology Business (2015-2020)
13.9.5 Perkinelmer Recent Development
13.10 SRI International
13.10.1 SRI International Company Details
13.10.2 SRI International Business Overview
13.10.3 SRI International In Vivo Toxicology Introduction
13.10.4 SRI International Revenue in In Vivo Toxicology Business (2015-2020)
13.10.5 SRI International Recent Development
13.11 Taconic Biosciences
10.11.1 Taconic Biosciences Company Details
10.11.2 Taconic Biosciences Business Overview
10.11.3 Taconic Biosciences In Vivo Toxicology Introduction
10.11.4 Taconic Biosciences Revenue in In Vivo Toxicology Business (2015-2020)
10.11.5 Taconic Biosciences Recent Development
13.12 Wuxi Apptec
10.12.1 Wuxi Apptec Company Details
10.12.2 Wuxi Apptec Business Overview
10.12.3 Wuxi Apptec In Vivo Toxicology Introduction
10.12.4 Wuxi Apptec Revenue in In Vivo Toxicology Business (2015-2020)
10.12.5 Wuxi Apptec Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. In Vivo Toxicology Key Market Segments
Table 2. Key Players Covered: Ranking by In Vivo Toxicology Revenue
Table 3. Ranking of Global Top In Vivo Toxicology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global In Vivo Toxicology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chronic Toxicity Testing
Table 6. Key Players of Sub-Chronic Toxicity Testing
Table 7. Key Players of Sub-Acute Toxicity Testing
Table 8. Key Players of Acute Toxicity Testing
Table 9. Global In Vivo Toxicology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global In Vivo Toxicology Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global In Vivo Toxicology Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global In Vivo Toxicology Market Share by Regions (2015-2020)
Table 13. Global In Vivo Toxicology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global In Vivo Toxicology Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. In Vivo Toxicology Market Growth Strategy
Table 19. Main Points Interviewed from Key In Vivo Toxicology Players
Table 20. Global In Vivo Toxicology Revenue by Players (2015-2020) (Million US$)
Table 21. Global In Vivo Toxicology Market Share by Players (2015-2020)
Table 22. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vivo Toxicology as of 2019)
Table 23. Global In Vivo Toxicology by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players In Vivo Toxicology Product Solution and Service
Table 26. Date of Enter into In Vivo Toxicology Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 29. Global In Vivo Toxicology Market Size Share by Type (2015-2020)
Table 30. Global In Vivo Toxicology Revenue Market Share by Type (2021-2026)
Table 31. Global In Vivo Toxicology Market Size Share by Application (2015-2020)
Table 32. Global In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 33. Global In Vivo Toxicology Market Size Share by Application (2021-2026)
Table 34. North America Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 35. North America Key Players In Vivo Toxicology Market Share (2019-2020)
Table 36. North America In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 37. North America In Vivo Toxicology Market Share by Type (2015-2020)
Table 38. North America In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 39. North America In Vivo Toxicology Market Share by Application (2015-2020)
Table 40. Europe Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players In Vivo Toxicology Market Share (2019-2020)
Table 42. Europe In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 43. Europe In Vivo Toxicology Market Share by Type (2015-2020)
Table 44. Europe In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 45. Europe In Vivo Toxicology Market Share by Application (2015-2020)
Table 46. China Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 47. China Key Players In Vivo Toxicology Market Share (2019-2020)
Table 48. China In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 49. China In Vivo Toxicology Market Share by Type (2015-2020)
Table 50. China In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 51. China In Vivo Toxicology Market Share by Application (2015-2020)
Table 52. Japan Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players In Vivo Toxicology Market Share (2019-2020)
Table 54. Japan In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 55. Japan In Vivo Toxicology Market Share by Type (2015-2020)
Table 56. Japan In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 57. Japan In Vivo Toxicology Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players In Vivo Toxicology Market Share (2019-2020)
Table 60. Southeast Asia In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia In Vivo Toxicology Market Share by Type (2015-2020)
Table 62. Southeast Asia In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia In Vivo Toxicology Market Share by Application (2015-2020)
Table 64. India Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 65. India Key Players In Vivo Toxicology Market Share (2019-2020)
Table 66. India In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 67. India In Vivo Toxicology Market Share by Type (2015-2020)
Table 68. India In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 69. India In Vivo Toxicology Market Share by Application (2015-2020)
Table 70. Central & South America Key Players In Vivo Toxicology Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players In Vivo Toxicology Market Share (2019-2020)
Table 72. Central & South America In Vivo Toxicology Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America In Vivo Toxicology Market Share by Type (2015-2020)
Table 74. Central & South America In Vivo Toxicology Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America In Vivo Toxicology Market Share by Application (2015-2020)
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Product
Table 79. Thermo Fisher Scientific Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Danaher Company Details
Table 82. Danaher Business Overview
Table 83. Danaher Product
Table 84. Danaher Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 85. Danaher Recent Development
Table 86. Charles River Laboratories Company Details
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Product
Table 89. Charles River Laboratories Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 90. Charles River Laboratories Recent Development
Table 91. Labcorp Company Details
Table 92. Labcorp Business Overview
Table 93. Labcorp Product
Table 94. Labcorp Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 95. Labcorp Recent Development
Table 96. The Jackson Laboratory Company Details
Table 97. The Jackson Laboratory Business Overview
Table 98. The Jackson Laboratory Product
Table 99. The Jackson Laboratory Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 100. The Jackson Laboratory Recent Development
Table 101. Data Sciences International Company Details
Table 102. Data Sciences International Business Overview
Table 103. Data Sciences International Product
Table 104. Data Sciences International Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 105. Data Sciences International Recent Development
Table 106. Envigo Company Details
Table 107. Envigo Business Overview
Table 108. Envigo Product
Table 109. Envigo Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 110. Envigo Recent Development
Table 111. Eurofins Scientific Business Overview
Table 112. Eurofins Scientific Product
Table 113. Eurofins Scientific Company Details
Table 114. Eurofins Scientific Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 115. Eurofins Scientific Recent Development
Table 116. Perkinelmer Company Details
Table 117. Perkinelmer Business Overview
Table 118. Perkinelmer Product
Table 119. Perkinelmer Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 120. Perkinelmer Recent Development
Table 121. SRI International Company Details
Table 122. SRI International Business Overview
Table 123. SRI International Product
Table 124. SRI International Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 125. SRI International Recent Development
Table 126. Taconic Biosciences Company Details
Table 127. Taconic Biosciences Business Overview
Table 128. Taconic Biosciences Product
Table 129. Taconic Biosciences Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 130. Taconic Biosciences Recent Development
Table 131. Wuxi Apptec Company Details
Table 132. Wuxi Apptec Business Overview
Table 133. Wuxi Apptec Product
Table 134. Wuxi Apptec Revenue in In Vivo Toxicology Business (2015-2020) (Million US$)
Table 135. Wuxi Apptec Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vivo Toxicology Market Share by Type: 2020 VS 2026
Figure 2. Chronic Toxicity Testing Features
Figure 3. Sub-Chronic Toxicity Testing Features
Figure 4. Sub-Acute Toxicity Testing Features
Figure 5. Acute Toxicity Testing Features
Figure 6. Global In Vivo Toxicology Market Share by Application: 2020 VS 2026
Figure 7. Immunotoxicity Case Studies
Figure 8. Systemic Toxicity Case Studies
Figure 9. Carcinogenicity Case Studies
Figure 10. Genotoxicity Case Studies
Figure 11. Developmental and Reproductive Toxicity (DART) Case Studies
Figure 12. Other Toxicity Endpoints Case Studies
Figure 13. In Vivo Toxicology Report Years Considered
Figure 14. Global In Vivo Toxicology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global In Vivo Toxicology Market Share by Regions: 2020 VS 2026
Figure 16. Global In Vivo Toxicology Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global In Vivo Toxicology Market Share by Players in 2019
Figure 19. Global Top In Vivo Toxicology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vivo Toxicology as of 2019
Figure 20. The Top 10 and 5 Players Market Share by In Vivo Toxicology Revenue in 2019
Figure 21. North America In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America In Vivo Toxicology Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
体外毒性試験の世界市場（～2026年） In-vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. Significant progress in toxicology science is one of the key trends escalating market growth. Besides this, socio-ethical concerns pertaining to animal tests and …- 毒性検査の世界市場（～2026年） The toxicology testing market includes safety assessment of chemicals, drugs, cosmetic products, food additives, etc, without using animals as test models. This testing is performed on advance cell and tissue models to determine safety by studying the potential of the test substances to cause toxici…
- ADME毒性試験の世界市場（～2026年） ADME testing refers to the pharmacokinetic testing of a compound in living organism and known as ADME/Tox. Drug development is a cost and time intensive process. The traditional drug development process includes toxicity and efficacy testing in in-vivo environment which is responsible for late stage…
- 体外毒性検査の世界市場（～2026年） In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early st…
- 耐火性・発煙性・毒耐性複合樹脂の世界市場（～2026年） A FST composite resin is a substance that reduces the spread of fire, smoke, toxic gases or delays their entry into sensitive areas. The increased use of composite components in the interior application of high speed, monorail, metro, trams, intercity, commuter rails and so on are driving the growth…